|
NFKBIL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.41788836017076E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49040000235945E-08 |
| Normal-vs-Stage2 |
1.626480E-02 |
| Normal-vs-Stage3 |
2.12599999999119E-05 |
| Normal-vs-Stage4 |
7.437800E-03 |
| Stage1-vs-Stage2 |
5.662800E-01 |
| Stage1-vs-Stage3 |
8.895500E-03 |
| Stage1-vs-Stage4 |
1.543370E-01 |
| Stage2-vs-Stage3 |
1.386840E-01 |
| Stage2-vs-Stage4 |
6.008800E-01 |
| Stage3-vs-Stage4 |
4.529600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.94353430518868E-12 |
| Normal-vs-AfricanAmerican |
2.05730000002458E-06 |
| Normal-vs-Asian |
2.51240000004316E-06 |
| Caucasian-vs-AfricanAmerican |
4.540400E-01 |
| Caucasian-vs-Asian |
6.757400E-01 |
| AfricanAmerican-vs-Asian |
4.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.93864973758218E-12 |
| Normal-vs-Female |
1.29349999600237E-08 |
| Male-vs-Female |
9.896500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.36930000000668E-05 |
| Normal-vs-Extreme_Weight |
2.67400000031337E-07 |
| Normal-vs-Obese |
3.28479999867071E-08 |
| Normal-vs-Extreme_Obese |
2.548600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.945400E-01 |
| Normal_Weight-vs-Obese |
2.188400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.842970E-01 |
| Extreme_Weight-vs-Obese |
6.470100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.196200E-01 |
| Obese-vs-Extreme_Obese |
6.872400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.10550000000676E-05 |
| Normal-vs-Age(41-60Yrs) |
8.76609895783531E-11 |
| Normal-vs-Age(61-80Yrs) |
1.89920001947286E-09 |
| Normal-vs-Age(81-100Yrs) |
7.895800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.171500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.005210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.473000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.402000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.799400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.976000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.79511960851642E-12 |
| Normal-VS-Type2 PRCC |
1.038300E-03 |
| Normal-VS-KIRP CIMP |
6.625700E-04 |
| Normal-VS-Unclassified PRCC |
1.965910E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.456900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.641800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.466600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.15289999999846E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
4.517700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.140020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.5801000000042E-05 |
| Normal-vs-N1 |
6.01259999999382E-05 |
| Normal-vs-N2 |
1.351040E-01 |
| N0-vs-N1 |
1.772120E-02 |
| N0-vs-N2 |
1.963980E-01 |
| N1-vs-N2 |
8.702000E-01 |
|
|
